1 Encorafenib Market Overview 1.1 Encorafenib Product Overview 1.2 Encorafenib Market Segment by Type 1.2.1 50mg Capsules 1.2.2 75mg Capsules 1.3 Global Encorafenib Market Size by Type 1.3.1 Global Encorafenib Market Size Overview by Type (2016-2027) 1.3.2 Global Encorafenib Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Encorafenib Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Encorafenib Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Encorafenib Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Encorafenib Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Encorafenib Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Encorafenib Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Encorafenib Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Encorafenib Sales Breakdown by Type (2016-2021) 1.4.2 Europe Encorafenib Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Encorafenib Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Encorafenib Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Encorafenib Sales Breakdown by Type (2016-2021) 2 Global Encorafenib Market Competition by Company 2.1 Global Top Players by Encorafenib Sales (2016-2021) 2.2 Global Top Players by Encorafenib Revenue (2016-2021) 2.3 Global Top Players Encorafenib Price (2016-2021) 2.4 Global Top Manufacturers Encorafenib Manufacturing Base Distribution, Sales Area, Product Type 2.5 Encorafenib Market Competitive Situation and Trends 2.5.1 Encorafenib Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Encorafenib Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Encorafenib as of 2020) 2.7 Date of Key Manufacturers Enter into Encorafenib Market 2.8 Key Manufacturers Encorafenib Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Encorafenib Status and Outlook by Region 3.1 Global Encorafenib Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Encorafenib Historic Market Size by Region 3.2.1 Global Encorafenib Sales in Volume by Region (2016-2021) 3.2.2 Global Encorafenib Sales in Value by Region (2016-2021) 3.2.3 Global Encorafenib Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Encorafenib Forecasted Market Size by Region 3.3.1 Global Encorafenib Sales in Volume by Region (2022-2027) 3.3.2 Global Encorafenib Sales in Value by Region (2022-2027) 3.3.3 Global Encorafenib Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Encorafenib by Application 4.1 Encorafenib Market Segment by Application 4.1.1 Hospital 4.1.2 Clinic 4.1.3 Pharmacy 4.1.4 Other 4.2 Global Encorafenib Market Size by Application 4.2.1 Global Encorafenib Market Size Overview by Application (2016-2027) 4.2.2 Global Encorafenib Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Encorafenib Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Encorafenib Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Encorafenib Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Encorafenib Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Encorafenib Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Encorafenib Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Encorafenib Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Encorafenib Sales Breakdown by Application (2016-2021) 4.3.2 Europe Encorafenib Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Encorafenib Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Encorafenib Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Encorafenib Sales Breakdown by Application (2016-2021) 5 North America Encorafenib by Country 5.1 North America Encorafenib Historic Market Size by Country 5.1.1 North America Encorafenib Sales in Volume by Country (2016-2021) 5.1.2 North America Encorafenib Sales in Value by Country (2016-2021) 5.2 North America Encorafenib Forecasted Market Size by Country 5.2.1 North America Encorafenib Sales in Volume by Country (2022-2027) 5.2.2 North America Encorafenib Sales in Value by Country (2022-2027) 6 Europe Encorafenib by Country 6.1 Europe Encorafenib Historic Market Size by Country 6.1.1 Europe Encorafenib Sales in Volume by Country (2016-2021) 6.1.2 Europe Encorafenib Sales in Value by Country (2016-2021) 6.2 Europe Encorafenib Forecasted Market Size by Country 6.2.1 Europe Encorafenib Sales in Volume by Country (2022-2027) 6.2.2 Europe Encorafenib Sales in Value by Country (2022-2027) 7 Asia-Pacific Encorafenib by Region 7.1 Asia-Pacific Encorafenib Historic Market Size by Region 7.1.1 Asia-Pacific Encorafenib Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Encorafenib Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Encorafenib Forecasted Market Size by Region 7.2.1 Asia-Pacific Encorafenib Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Encorafenib Sales in Value by Region (2022-2027) 8 Latin America Encorafenib by Country 8.1 Latin America Encorafenib Historic Market Size by Country 8.1.1 Latin America Encorafenib Sales in Volume by Country (2016-2021) 8.1.2 Latin America Encorafenib Sales in Value by Country (2016-2021) 8.2 Latin America Encorafenib Forecasted Market Size by Country 8.2.1 Latin America Encorafenib Sales in Volume by Country (2022-2027) 8.2.2 Latin America Encorafenib Sales in Value by Country (2022-2027) 9 Middle East and Africa Encorafenib by Country 9.1 Middle East and Africa Encorafenib Historic Market Size by Country 9.1.1 Middle East and Africa Encorafenib Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Encorafenib Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Encorafenib Forecasted Market Size by Country 9.2.1 Middle East and Africa Encorafenib Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Encorafenib Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Encorafenib Business 10.1 Array BioPharma 10.1.1 Array BioPharma Corporation Information 10.1.2 Array BioPharma Introduction and Business Overview 10.1.3 Array BioPharma Encorafenib Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Array BioPharma Encorafenib Products Offered 10.1.5 Array BioPharma Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Encorafenib Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Encorafenib Industrial Chain Analysis 11.4 Encorafenib Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Encorafenib Distributors 12.3 Encorafenib Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of 50mg Capsules Table 2. Major Company of 75mg Capsules Table 3. Global Encorafenib Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 4. Global Encorafenib Sales by Type (2016-2021) & (K Pcs) Table 5. Global Encorafenib Sales Market Share in Volume by Type (2016-2021) Table 6. Global Encorafenib Sales by Type (2016-2021) & (US& Million) Table 7. Global Encorafenib Market Share in Value by Type (2016-2021) Table 8. Global Encorafenib Price by Type (2016-2021) & (USD/Pcs) Table 9. Global Encorafenib Sales by Type (2022-2027) & (K Pcs) Table 10. Global Encorafenib Sales Market Share in Volume by Type (2022-2027) Table 11. Global Encorafenib Sales by Type (2022-2027) & (US$ Million) Table 12. Global Encorafenib Sales Market Share in Value by Type (2022-2027) Table 13. Global Encorafenib Price by Type (2022-2027) & (USD/Pcs) Table 14. North America Encorafenib Sales by Type (2016-2021) & (K Pcs) Table 15. North America Encorafenib Sales by Type (2016-2021) & (US$ Million) Table 16. Europe Encorafenib Sales (K Pcs) by Type (2016-2021) Table 17. Europe Encorafenib Sales by Type (2016-2021) & (US$ Million) Table 18. Asia-Pacific Encorafenib Sales (K Pcs) by Type (2016-2021) Table 19. Asia-Pacific Encorafenib Sales by Type (2016-2021) & (US$ Million) Table 20. Latin America Encorafenib Sales (K Pcs) by Type (2016-2021) Table 21. Latin America Encorafenib Sales by Type (2016-2021) & (US$ Million) Table 22. Middle East and Africa Encorafenib Sales (K Pcs) by Type (2016-2021) Table 23. Middle East and Africa Encorafenib Sales by Type (2016-2021) & (US$ Million) Table 24. Global Encorafenib Sales by Company (2016-2021) & (K Pcs) Table 25. Global Encorafenib Sales Share by Company (2016-2021) Table 26. Global Encorafenib Revenue by Company (2016-2021) & (US$ Million) Table 27. Global Encorafenib Revenue Share by Company (2016-2021) Table 28. Global Market Encorafenib Price by Company (2016-2021) & (USD/Pcs) Table 29. Global Encorafenib Top Manufacturers Manufacturing Base Distribution and Sales Area Table 30. Global Encorafenib Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Encorafenib as of 2020 Table 32. Date of Key Manufacturers Enter into Encorafenib Market Table 33. Key Manufacturers Encorafenib Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Encorafenib Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 36. Global Encorafenib Sales by Region (2016-2021) & (K Pcs) Table 37. Global Encorafenib Sales Market Share in Volume by Region (2016-2021) Table 38. Global Encorafenib Sales by Region (2016-2021) & (US$ Million) Table 39. Global Encorafenib Sales Market Share in Value by Region (2016-2021) Table 40. Global Encorafenib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 41. Global Encorafenib Sales by Region (2022-2027) & (K Pcs) Table 42. Global Encorafenib Sales Market Share in Volume by Region (2022-2027) Table 43. Global Encorafenib Sales by Region (2022-2027) & (US$ Million) Table 44. Global Encorafenib Sales Market Share in Value by Region (2022-2027) Table 45. Global Encorafenib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2022-2027) Table 46. Global Encorafenib Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 47. Global Encorafenib Sales by Application (2016-2021) & (K Pcs) Table 48. Global Encorafenib Sales Market Share in Volume by Application (2016-2021) Table 49. Global Encorafenib Sales by Application (2016-2021) & (US$ Million) Table 50. Global Encorafenib Sales Market Share in Value by Application (2016-2021) Table 51. Global Encorafenib Price by Application (2016-2021) & (USD/Pcs) Table 52. Global Encorafenib Sales by Application (2022-2027) & (K Pcs) Table 53. Global Encorafenib Sales Market Share in Volume by Application (2022-2027) Table 54. Global Encorafenib Sales by Application (2022-2027) & (US$ Million) Table 55. Global Encorafenib Sales Market Share in Value by Application (2022-2027) Table 56. Global Encorafenib Price by Application (2022-2027) & (USD/Pcs) Table 57. North America Encorafenib Sales by Application (2016-2021) (K Pcs) Table 58. North America Encorafenib Sales by Application (2016-2021) & (US$ Million) Table 59. North America Encorafenib Sales Market Share in Value by Application in 2020 Table 60. Europe Encorafenib Sales by Application (2016-2021) (K Pcs) Table 61. Europe Encorafenib Sales by Application (2016-2021) & (US$ Million) Table 62. Europe Encorafenib Sales Market Share in Value by Application in 2020 Table 63. Asia-Pacific Encorafenib Sales by Application (2016-2021) (K Pcs) Table 64. Asia-Pacific Encorafenib Sales by Application (2016-2021) & (US$ Million) Table 65. Asia-Pacific Encorafenib Sales Market Share in Value by Application in 2020 Table 66. Latin America Encorafenib Sales by Application (2016-2021) (K Pcs) Table 67. Latin America Encorafenib Sales by Application (2016-2021) & (US$ Million) Table 68. Latin America Encorafenib Sales Market Share in Value by Application in 2020 Table 69. Middle East and Africa Encorafenib Sales by Application (2016-2021) (K Pcs) Table 70. Middle East and Africa Encorafenib Sales by Application (2016-2021) & (US$ Million) Table 71. Middle East and Africa Encorafenib Sales Market Share in Value by Application in 2020 Table 72. North America Encorafenib Sales by Country (2016-2021) & (K Pcs) Table 73. North America Encorafenib Sales Market Share in Volume by Country (2016-2021) Table 74. North America Encorafenib Sales by Country (2016-2021) & (US$ Million) Table 75. North America Encorafenib Sales Market Share in Value by Country (2016-2021) Table 76. North America Encorafenib Sales by Country (2022-2027) & (K Pcs) Table 77. North America Encorafenib Sales Market Share in Volume by Country (2022-2027) Table 78. North America Encorafenib Sales by Country (2022-2027) & (US$ Million) Table 79. North America Encorafenib Sales Market Share in Value by Country (2022-2027) Table 80. Europe Encorafenib Sales by Country (2016-2021) & (K Pcs) Table 81. Europe Encorafenib Sales Market Share in Volume by Country (2016-2021) Table 82. Europe Encorafenib Sales by Country (2016-2021) & (US$ Million) Table 83. Europe Encorafenib Sales Market Share in Value by Country (2016-2021) Table 84. Europe Encorafenib Sales by Country (2022-2027) & (K Pcs) Table 85. Europe Encorafenib Sales Market Share in Volume by Country (2022-2027) Table 86. Europe Encorafenib Sales by Country (2022-2027) & (US$ Million) Table 87. Europe Encorafenib Sales Market Share in Value by Country (2022-2027) Table 88. Asia-Pacific Encorafenib Sales by Region (2016-2021) & (K Pcs) Table 89. Asia-Pacific Encorafenib Sales Market Share in Volume by Region (2016-2021) Table 90. Asia-Pacific Encorafenib Sales by Region (2016-2021) & (US$ Million) Table 91. Asia-Pacific Encorafenib Sales Market Share in Value by Region (2016-2021) Table 92. Asia-Pacific Encorafenib Sales by Region (2022-2027) & (K Pcs) Table 93. Asia-Pacific Encorafenib Sales Market Share in Volume by Region (2022-2027) Table 94. Asia-Pacific Encorafenib Sales by Region (2022-2027) & (US$ Million) Table 95. Asia-Pacific Encorafenib Sales Market Share in Value by Region (2022-2027) Table 96. Latin America Encorafenib Sales by Country (2016-2021) & (K Pcs) Table 97. Latin America Encorafenib Sales Market Share in Volume by Country (2016-2021) Table 98. Latin America Encorafenib Sales by Country (2016-2021) & (US$ Million) Table 99. Latin America Encorafenib Sales Market Share in Value by Country (2016-2021) Table 100. Latin America Encorafenib Sales by Country (2022-2027) & (K Pcs) Table 101. Latin America Encorafenib Sales Market Share in Volume by Country (2022-2027) Table 102. Latin America Encorafenib Sales by Country (2022-2027) & (US$ Million) Table 103. Latin America Encorafenib Sales Market Share in Value by Country (2022-2027) Table 104. Middle East and Africa Encorafenib Sales by Country (2016-2021) & (K Pcs) Table 105. Middle East and Africa Encorafenib Sales Market Share in Volume by Country (2016-2021) Table 106. Middle East and Africa Encorafenib Sales by Country (2016-2021) & (US$ Million) Table 107. Middle East and Africa Encorafenib Sales Market Share in Value by Country (2016-2021) Table 108. Middle East and Africa Encorafenib Sales by Country (2022-2027) & (K Pcs) Table 109. Middle East and Africa Encorafenib Sales Market Share in Volume by Country (2022-2027) Table 110. Middle East and Africa Encorafenib Sales by Country (2022-2027) & (US$ Million) Table 111. Middle East and Africa Encorafenib Sales Market Share in Value by Country (2022-2027) Table 112. Array BioPharma Corporation Information Table 113. Array BioPharma Introduction and Business Overview Table 114. Array BioPharma Encorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 115. Array BioPharma Encorafenib Product Table 116. Array BioPharma Recent Development Table 117. Key Raw Materials Lists Table 118. Raw Materials Key Suppliers Lists Table 119. Encorafenib Market Trends Table 120. Encorafenib Market Drivers Table 121. Encorafenib Market Challenges Table 122. Encorafenib Market Restraints Table 123. Encorafenib Distributors List Table 124. Encorafenib Downstream Customers Table 125. Research Programs/Design for This Report Table 126. Key Data Information from Secondary Sources Table 127. Key Data Information from Primary Sources List of Figures Figure 1. Encorafenib Product Picture Figure 2. Global Encorafenib Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Encorafenib Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Encorafenib Sales Status and Outlook (2016-2027) & (K Pcs) Figure 5. Product Picture of 50mg Capsules Figure 6. Global 50mg Capsules Sales YoY Growth (2016-2021) & (K Pcs) Figure 7. Product Picture of 75mg Capsules Figure 8. Global 75mg Capsules Sales YoY Growth (2016-2021) & (K Pcs) Figure 9. Global Encorafenib Sales by Type (2016-2027) & (US$ Million) Figure 10. Global Encorafenib Sales Market Share in Volume by Type (2016-2021) Figure 11. Global Encorafenib Sales Market Share in Value by Type (2016-2021) Figure 12. Global Encorafenib Sales Market Share in Volume by Type (2022-2027) Figure 13. Global Encorafenib Sales Market Share in Value by Type (2022-2027) Figure 14. North America Encorafenib Sales Market Share in Volume by Type in 2020 Figure 15. North America Encorafenib Sales Market Share in Value by Type in 2020 Figure 16. Europe Encorafenib Sales Market Share in Volume by Type in 2020 Figure 17. Europe Encorafenib Sales Market Share in Value by Type in 2020 Figure 18. Asia-Pacific Encorafenib Sales Market Share in Volume by Type in 2020 Figure 19. Asia-Pacific Encorafenib Sales Market Share in Value by Type in 2020 Figure 20. Latin America Encorafenib Sales Market Share in Volume by Type in 2020 Figure 21. Latin America Encorafenib Sales Market Share in Value by Type in 2020 Figure 22. Middle East and Africa Encorafenib Sales Market Share in Volume by Type in 2020 Figure 23. Middle East and Africa Encorafenib Sales Market Share in Value by Type in 2020 Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Encorafenib Sales in 2020 Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Encorafenib Revenue in 2020 Figure 26. Encorafenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 27. Product Picture of Hospital Figure 28. Global Hospital Sales YoY Growth (2016-2027) & (K Pcs) Figure 29. Product Picture of Clinic Figure 30. Global Clinic Sales YoY Growth (2016-2027) & (K Pcs) Figure 31. Product Picture of Pharmacy Figure 32. Global Pharmacy Sales YoY Growth (2016-2027) & (K Pcs) Figure 33. Product Picture of Other Figure 34. Global Other Sales YoY Growth (2016-2027) & (K Pcs) Figure 35. Global Encorafenib Sales by Application (2016-2027) & (US$ Million) Figure 36. Global Encorafenib Sales Market Share in Volume by Application (2016-2021) Figure 37. Global Encorafenib Sales Market Share in Value by Application (2016-2021) Figure 38. Global Encorafenib Sales Market Share in Volume by Application (2022-2027) Figure 39. North America Encorafenib Sales Market Share in Volume by Application in 2020 Figure 40. Latin America Encorafenib Sales Market Share in Value by Application in 2020 Figure 41. Middle East and Africa Encorafenib Sales Market Share in Value by Application in 2020 Figure 42. Key Raw Materials Price Figure 43. Encorafenib Manufacturing Cost Structure Figure 44. Encorafenib Industrial Chain Analysis Figure 45. Channels of Distribution Figure 46. Distributors Profiles Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation Figure 49. Key Executives Interviewed

Array BioPharma